The Relationship Between Rosacea and Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

Abstract Introduction Rosacea and inflammatory bowel disease (IBD) are chronic inflammatory disorders of the skin and the gut, which are interfaces between the environment and the human body. Although growing evidence has implicated a possible link between rosacea and IBD, it remains unclear whether...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu Kyung Jun (Author), Da-Ae Yu (Author), Yoo Min Han (Author), Soo Ran Lee (Author), Seong-Joon Koh (Author), Hyunsun Park (Author)
Format: Book
Published: Adis, Springer Healthcare, 2023-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a6e8893f3dc749ccb38c7922f2c4ba0c
042 |a dc 
100 1 0 |a Yu Kyung Jun  |e author 
700 1 0 |a Da-Ae Yu  |e author 
700 1 0 |a Yoo Min Han  |e author 
700 1 0 |a Soo Ran Lee  |e author 
700 1 0 |a Seong-Joon Koh  |e author 
700 1 0 |a Hyunsun Park  |e author 
245 0 0 |a The Relationship Between Rosacea and Inflammatory Bowel Disease: A Systematic Review and Meta-analysis 
260 |b Adis, Springer Healthcare,   |c 2023-06-01T00:00:00Z. 
500 |a 10.1007/s13555-023-00964-6 
500 |a 2193-8210 
500 |a 2190-9172 
520 |a Abstract Introduction Rosacea and inflammatory bowel disease (IBD) are chronic inflammatory disorders of the skin and the gut, which are interfaces between the environment and the human body. Although growing evidence has implicated a possible link between rosacea and IBD, it remains unclear whether IBD increases the risk of rosacea and vice versa. Therefore, we investigated the association between rosacea and IBD in this study. Methods We performed a systematic review and meta-analysis according to the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) guidelines. Results Eight eligible studies were included in this meta-analysis. Overall, the prevalence of rosacea was higher in the IBD group than in the control group, with a pooled odds ratio (OR) of 1.86 (95% confidence interval [CI](1), 1.52-2.26). Both the Crohn's disease and the ulcerative colitis groups had higher prevalences of rosacea than the control group, with ORs of 1.74 (95% CI 1.34-2.28) and 2.00 (95% CI 1.63-2.45), respectively. Compared with those in the control group, the risks of IBD, Crohn's disease, and ulcerative colitis were significantly higher in the rosacea group, with incidence rate ratios of 1.37 (95% CI 1.22-1.53), 1.60 (95% CI 1.33-1.92), and 1.26 (95% CI 1.09-1.45), respectively. Conclusion Our meta-analysis suggests that IBD is bidirectionally associated with rosacea. Future interdisciplinary studies are needed to better understand the mechanism of interaction between rosacea and IBD . 
546 |a EN 
690 |a Rosacea 
690 |a Inflammatory bowel disease 
690 |a Systematic review 
690 |a Meta-analysis 
690 |a Colitis 
690 |a Ulcerative 
690 |a Dermatology 
690 |a RL1-803 
655 7 |a article  |2 local 
786 0 |n Dermatology and Therapy, Vol 13, Iss 7, Pp 1465-1475 (2023) 
787 0 |n https://doi.org/10.1007/s13555-023-00964-6 
787 0 |n https://doaj.org/toc/2193-8210 
787 0 |n https://doaj.org/toc/2190-9172 
856 4 1 |u https://doaj.org/article/a6e8893f3dc749ccb38c7922f2c4ba0c  |z Connect to this object online.